Board Of Trustees Of The Leland Stanford Junior University Renovo Rx, Inc. Transaction History

Board Of Trustees Of The Leland Stanford Junior University

  • $1.17 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$2.87 - $4.9 $174,676 - $298,228
-60,863 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$6.04 - $16.02 $367,612 - $975,025
60,863 New
60,863 $368,000

Others Institutions Holding RNXT

# of Institutions
16
Shares Held
2.87M
Call Options Held
0
Put Options Held
0
View Full List

About RenovoRx, Inc.

RNXT Quotes by TradingView
  • Ticker RNXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,066,860
  • Market Cap $11.3M
  • Description
  • RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...
More about RNXT
Track This Portfolio

Track Board Of Trustees Of The Leland Stanford Junior University Portfolio

Follow Board Of Trustees Of The Leland Stanford Junior University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email